
Phil Rivers Technology offers an AI-driven platform that helps researchers identify oncology drug targets and predict patient responders. It combines biotechnology data with digital twin models, machine learning, and computational biology to map indications, prioritize targets, and forecast responders. The platform is used by pharmaceutical and biotechnology R&D teams and integrates with bioinformatics workflows and data pipelines. Phil Rivers Technology operates in the AI-enabled drug discovery category, focusing on target discovery and precision-response prediction for oncology programs.

Phil Rivers Technology offers an AI-driven platform that helps researchers identify oncology drug targets and predict patient responders. It combines biotechnology data with digital twin models, machine learning, and computational biology to map indications, prioritize targets, and forecast responders. The platform is used by pharmaceutical and biotechnology R&D teams and integrates with bioinformatics workflows and data pipelines. Phil Rivers Technology operates in the AI-enabled drug discovery category, focusing on target discovery and precision-response prediction for oncology programs.